Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
PHVS
Home
/
PHVS

NASDAQ
$34.33
$34.33

Overview

Price performance
Low
$33.13
High
$35.29
Market closed. Last updated: Nov 4, 2026, 9:00 PM UTC
$
34.33
-0.45 (-1.29%)
Average, 50 days
$33.56
$31.08
Open
$35.25
Previous close
$34.78
52-week high
$43.25
Sep 8, 2026 (2 months ago)
52-week low
$21.02
Nov 7, 2025 (13 months ago)
63.32%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
2.40B
Volume
309 268
Total Return (3M)
1.36%
Total Return (1Y)
58.64%
6.88
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
CH
Website
pharvaris.com
About
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.

Frequently asked questions

PHVS · Pharvaris N.V.

01What is Pharvaris N.V. stock price today?

The current price of PHVS is $34.33 — it has decreased by 1.29% since the previous close. Data as of Nov 4, 2026.

02Is Pharvaris N.V. stock price growing?

PHVS is up 2.54% over the past week, up 10.07% over the past month and up 58.64% over the past year. The price is above its 200-day moving average of $31.08.

03What do analysts say about PHVS stock?

Of the 14 analysts covering Pharvaris N.V., 3 rate it a strong buy and 11 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

04What is Pharvaris N.V. market cap?

Pharvaris N.V. has a market capitalization of $2.4B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

05Does Pharvaris N.V. pay dividends?

Pharvaris N.V. has not paid any dividends over the past year.

06How volatile is PHVS stock?

In the latest trading session PHVS moved between $33.13 and $35.29, a range of 6.31% of its current price.

07Should I invest in Pharvaris N.V. stock?

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Pharvaris N.V. shows a buy rating today. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Pharvaris N.V. is strong buy. Technical ratings are indicators, not investment advice.

08What are PHVS stock 52-week high and low?

Over the past 52 weeks PHVS has traded between $21.02 and $43.25. The current price is 20.62% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.